Signaling molecules of the endometrium: Gerontological and general pathological aspects

In: Advances in Gerontology · 2016 · vol. 6(1) , pp. 36–43 · doi:10.1134/s2079057016010045 · W2323173185
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-06-13

This review examines neuroendocrine and immune signaling molecules in human endometrial cells, detailing their synthesis and altered expression in aging and diseases like endometriosis, cancer, and infertility for potential therapeutic and diagnostic applications.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-13 · read from full text

This review examines how human endometrial cells express neuroendocrine and immune signaling molecules—including steroid hormones, adhesion molecules, growth factors, cytokines/chemokines, immune-cell markers, and heat-shock proteins—across normal function, pathological states, and aging. It synthesizes findings that aberrant expression of these signaling networks underlies conditions such as endometriosis, endometrial cancer, and infertility, emphasizing neuroendocrine–immune interactions as potential targets for drug development, diagnostics, and assisted reproduction. A key limitation is that it is a broad narrative review that does not present new original experiments or a standardized meta-analysis across studies. Relevance to endometriosis: the paper explicitly links dysregulated endometrial neuroendocrine/immune signaling molecules to endometriosis as one of the major “socially significant diseases” discussed, though endometriosis is not the sole focus of the review.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

This review describes the expression of neuroendocrine and immune signaling molecules in human endometrial cells under normal and pathological conditions and during aging. Human endometrial cells synthesize estrogen, progesterone, estradiol, progestin, cell-adhesion molecules (integrins α1β1, α4β1, αVβ3, L-selectin, E-cadherin, and MUC1), growth factors (TGF, EGF, HB-EGF, and IGF), cytokines (IL-1, IL-2, INF-α, IL-12, CXCL10, CXCL11, and CXCR3), various immune-cell markers (CD68, CD105, CD163, CD16, CD56, CD4, and CD8), and heat-shock proteins (HSP60, HSP70, HSP90, VEGF, and MMP). Aberrations in their expression levels underlie such socially significant diseases as endometriosis, endometrial cancer, and infertility. Thus, investigation of neuroendocrine and immune interactions among endometrial cells can be used for the purposes of drug development, differential diagnostics of endometrial cancer, and increasing the efficacy of in vitro fertilization.
Full text 8,065 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

This review describes the expression of neuroendocrine and immune signaling molecules in human endometrial cells under normal and pathological conditions and during aging. Human endometrial cells synthesize estrogen, progesterone, estradiol, progestin, cell-adhesion molecules (integrins α1β1, α4β1, αVβ3, L-selectin, E-cadherin, and MUC1), growth factors (TGF, EGF, HB-EGF, and IGF), cytokines (IL-1, IL-2, INF-α, IL-12, CXCL10, CXCL11, and CXCR3), various immune-cell markers (CD68, CD105, CD163, CD16, CD56, CD4, and CD8), and heat-shock proteins (HSP60, HSP70, HSP90, VEGF, and MMP). Aberrations in their expression levels underlie such socially significant diseases as endometriosis, endometrial cancer, and infertility. Thus, investigation of neuroendocrine and immune interactions among endometrial cells can be used for the purposes of drug development, differential diagnostics of endometrial cancer, and increasing the efficacy of in vitro fertilization. Similar content being viewed by others

References

Ailamazyan, E.K., Durnova, A.O., Polyakova, V.O., et al., Co-cultivation of human embryo with endometrium: optimization of extracorporal fertilization, Zh. Akush. Zhen. Bol., 2012, vol. 4, pp. 16–21. Ailamazyan, E.K., Petrosyan, M.A., Tolibova, G.Kh., et al., Culture of human endometrium: a model of reproductive function, Fundam. Med., 2012, vol. 12, no. 1, pp. 28–35. Artymuk, N.V., Gulyaeva, L.F., Ilenko, E.V., et al., Molecular and genetic aspects of oncology of female endometrium with neuroendocrine dysfunctions, Sib. Onkol. Zh., 2007, suppl. 5–7, pp. 21–25. Bokhman, Ya.V., Rukovodstvo po onkoginekologii (Guide on Oncogynecology), Moscow: Meditsina, 1989. Zaletaev, D.V., Strel’nikov, V.V., Nemtsova, M.V., et al., Structure-functional analysis of tumor genomes and development of test-systems for early diagnostics, course, and optimization of therapy of malignant neo lasms, Vestn. Ross. Akad. Med. Nauk, 2013, vol. 9, p. 7–14. Kuznetsova, I.V., Giperplasticheskie protsessy endometriya (Hyperplastic Processes in Endometrium), Moscow, 2009. Pal’tsev, M.A. and Kvetnoi, I.M., Rukovodstvo po neiroimmunoendokrinologii (Manual on Neuroimmunoendocrinology), Moscow: Shiko, 2014. Pal’tseva, E.M., Kekeeva, T.V., Zaletaev, D.V., and Nemtsova, M.V., The system of molecular markers in diagnostics of heavy uterus cervix dysplasia, in Sistemy geneticheskikh i epigeneticheskikh markerov v diagnostike onkologicheskikh zabolevanii (The Systems of Genetic and Molecular Markers in Diagnostics of Oncology), Pal’tsev, M.A. and Zaletaev, D.V., Ed., Moscow: Meditsina, 2009, pp. 215–224. Sheshukova, N.A., Makarov, I.O., and Ovsyannikova, T.V., Hyperplastic processes in endometrium: specific proliferative activity combined with chronic endometritis, Akush., Ginekol. Repord., 2011, vol. 3, pp. 10–15. Amir, W., Micha, B., Ariel, H., et al., Predicting factors for endometrial thickness during treatment with assisted reproductive technology, Fertil. Steril., 2007, vol. 87, no. 4, pp. 799–804. Blitek, A., Morawska-Pucinska, E., Szymanska, M., et al., Effect of conceptus on transforming growth factor (TGF) ß1 mRNA expression and protein concentration in the porcine endometrium—in vivo and in vitro studies, J. Reprod. Dev., 2013, vol. 59, no. 6, p. 512–519. Chen, N., Yi, X., Abushahin, N., et al., Nrf2 expression in endometrial serous carcinomas and its precancers, Int. J. Clin. Exp. Pathol., 2010, vol. 4, no. 1, pp. 85–96. Chethan, S.G., Singh, S.K., Nongsiej, J., et al., IFN-t acts in a dose-dependent manner on prostaglandin production by buffalo endometrial stromal cells cultured in vitro, Reprod. Domest. Anim., 2014, vol. 49, no. 3, p. 403–408. Cho, N.H., Park, Y.K., Kim, Y.T., et al., Lifetime expression of stem cell markers in the uterine endometrium, Fertil. Steril., 2004, vol. 81, no. 2, p. 403–407. Dharmaraj, N., Chapela, P.J., Morgado, M., et al., Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis, Hum. Reprod., 2014, vol. 29, no. 8, p. 1730–1738. Eskicioglu, F., Laçin, S., Ozbilgin, K., and Köse, C., The role of selectins in the first trimester pregnancy loss, Ginek. Pol., 2014, vol. 85, no. 4, pp. 287–293. Fábregas, F.F., Guimferrer, M.C., Casas, F.T., et al., Malignant transformation of abdominal wall endometriosis with lymph node metastasis, Gynecol. Oncol. Case Reprod., 2014, vol. 8, pp. 10–13. Ferquhar, C.M., Lethaby, A., and Sowter, M., An evaluation of risk factors for endometrial hyperplasia in remenopausal women with abnormal menstrual bleeding, Am. J. Obstet. Gynecol., 1999, vol. 181, no. 3, p. 525–529. Garcia-Velasco, J.A., Arici, A., Zreik, T., et al., Macrophage derived growth factors modulate Fas ligand expression in cultured endometrial stromal cells: a role in endometriosis, Mol. Hum. Reprod., 1999, vol. 5, no. 7, pp. 642–650. Gibran, L., Maranho, R.C., Abrao, M.S., et al., Could statins constitute a novel treatment for endometriosis? Systematic review of the literature, Eur. J. Obstet. Gynecol. Reprod. Biol., 2014, vol. 179, p. 153–158. Hale, G.E., Robertson, D.M., and Burger, H.G., The erimenopausal woman: endocrinology and management, J. Steroid Biochem. Mol. Biol., 2014, vol. 142, p. 121–131. Horn, L.C., Schnurbusch, U., Hentschel, B., and Einenkel, J., Risk of progression in complex and atypical endometrial hyperplasia: clinicipathologic analysis in cases with and without progestogen treatment II, Int. J. Gynecol. Cancer, 2004, vol. 14, no. 2, pp. 348–353. Huang, Y., Liu, Q., and Yu, Y., Relationship between fetal growth restriction and angiogenesis factors, J. South Med. Univ., 2014, vol. 34, no. 7, pp. 1068–1070. Kong, S., Zhang, Y.-H., Liu, C.-F., et al., The complementary and alternative medicine for endometriosis: a review of utilization and mechanism, J. EvidenceBased Complementary Altern. Med., 2014, vol. 23, p. 235–239. Montgomery, B.E., Damm, G.S., Dunton, C.J., et al., Endometrial hyperplasia: a review, Obstet. Gynecol. Surv., 2004, vol. 59, no. 5, pp. 368–378. Priyanka, H.P., Sharma, U., Gopinath, S., et al., Menstrual cycle and reproductive aging alters immune reactivity, NGF expression, antioxidant enzyme activities, and intracellular signaling pathways in the peripheral blood mononuclear cells of healthy women, Brain Behav. Immunol., 2013, vol. 32, pp. 131–143. Robertson, S.A. and Moldenhauer, L.M., Immunological determinants of implantation success, Int. J. Dev. Biol., 2014, vol. 58, nos. 2–4, pp. 205–217. Rubio, C., Simón, C., Mercader, A., et al., Clinical experience employing co-culture of human embryos with autologous human endometrial epithelial cells, Hum. Reprod., 2000, suppl. 6, pp. 31–38. Sak, M.E., Gul, T., Evsen, M.S., et al., Fibroblast growth factor-1 expression in the endometrium of atients with repeated implantation failure after in vitro fertilization, Eur. Rev. Med. Pharmacol. Sci., 2013, vol. 17, no. 3, pp. 398–402. Shirane, A., Wada-Hiraike, O., Tanikawa, M., et al., Regulation of SIRT1 determines initial step of endometrial receptivity by controlling E-cadherin expression, Biochem. Biophys. Res. Commun., 2012, vol. 424, no. 3, pp. 604–610. Teles, A. and Zenclussen, A.C., How cells of the immune system prepare the endometrium for implantation, Semin. Reprod. Med., 2014, vol. 32, no. 5, p. 358–364. Tilly, J.L. and Sinclair, D.A., Germline energetics, aging, and female infertility, Cell Metab., 2013, vol. 17, no. 6, pp. 838–850. Author information Authors and Affiliations Corresponding author Additional information Original Russian Text © I.Yu. Grigorian, N.S. Linkova, V.O. Polyakova, E.M. Paltseva, K.L. Kozlov, 2015, published in Uspekhi Gerontologii, 2015, Vol. 28, No. 3, pp. 453–461. Rights and permissions About this article Cite this article Grigorian, I.Y., Linkova, N.S., Polyakova, V.O. et al. Signaling molecules of the endometrium: Gerontological and general pathological aspects. Adv Gerontol 6, 36–43 (2016). https://doi.org/10.1134/S2079057016010045 Published: Issue date: DOI: https://doi.org/10.1134/S2079057016010045

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisinfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (25)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK